Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Nausea and vomiting |
Nausea and vomiting measured by Pregnancy-Unique-Quantification-of-Emesis-24 (PUQE-24) scale. Units of measure: 0-15 where higher score indicates more severe NVP. Categorization: 0-15, mild: =6 points, moderate: 7-12 points, severe: =13-15 points |
between baseline (Q1) and 2 weeks from baseline (Q2) |
|
Primary |
Nausea and vomiting |
Nausea and vomiting measured by Pregnancy-Unique-Quantification-of-Emesis-24 (PUQE-24) scale. Units of measure: 0-15 where higher score indicates more severe NVP. Categorization: 0-15, mild: =6 points, moderate: 7-12 points, severe: =13-15 points |
between baseline (Q1) and 4 weeks from baseline (Q3) |
|
Primary |
Nausea and vomiting |
Nausea and vomiting measured by Pregnancy-Unique-Quantification-of-Emesis-24 (PUQE-24) scale. Units of measure: 0-15 where higher score indicates more severe NVP. Categorization: 0-15, mild: =6 points, moderate: 7-12 points, severe: =13-15 points |
between baseline (Q1) and 6 weeks from baseline (Q4) |
|
Secondary |
Change in quality of life |
Quality of life measured by the Health-Related of Quality of Life for Nausea and Vomiting during Pregnancy" (NVPQOL). Score ranges from 30 to 210 points where lower scores indicate better quality of life |
between baseline (Q1) and 2 weeks from baseline (Q2) |
|
Secondary |
Change in quality of life |
Quality of life measured by the Health-Related of Quality of Life for Nausea and Vomiting during Pregnancy" (NVPQOL). Score ranges from 30 to 210 points where lower scores indicate better quality of life |
between baseline (Q1) and 4 weeks from baseline (Q3) |
|
Secondary |
Change in quality of life |
Quality of life measured by the Health-Related of Quality of Life for Nausea and Vomiting during Pregnancy" (NVPQOL). Score ranges from 30 to 210 points where lower scores indicate better quality of life |
between baseline (Q1) and 6 weeks from baseline (Q4) |
|
Secondary |
Decisional Conflict |
Decisional Conflict measured by Decisional Conflict Scale (DCS) questionnaire. Score ranges from 0 (no decisional conflict) to 100 (extreme high decisional conflict) |
between baseline (Q1) and 2 weeks from baseline (Q2) |
|
Secondary |
Decisional Conflict |
Decisional Conflict measured by Decisional Conflict Scale (DCS) questionnaire. Score ranges from 0 (no decisional conflict) to 100 (extreme high decisional conflict) |
between baseline (Q1) and 4 weeks from baseline (Q3) |
|
Secondary |
Decisional Conflict |
Decisional Conflict measured by Decisional Conflict Scale (DCS) questionnaire. Score ranges from 0 (no decisional conflict) to 100 (extreme high decisional conflict) |
between baseline (Q1) and 6 weeks from baseline (Q4) |
|
Secondary |
Knowledge |
10 statements about nausea and vomiting, measured by numbers of correct answers (agree/unsure/disagree). 80% correct considered as sufficient high knowledge |
Up to 40 weeks. Measured at four time points. Baseline (Q1), 2 (Q2), 4 (Q3), and 6 (Q4) weeks from baseline. |
|
Secondary |
Sick leave rates |
Self-reported sick leave rate in percentage |
Up to 40 weeks. Measured at four time points. Baseline (Q1), 2 (Q2), 4 (Q3), and 6 (Q4) weeks from baseline. |
|
Secondary |
Sick leave duration |
Self-reported sick leave duration in weeks among those with sick leave |
Up to 40 weeks |
|
Secondary |
Hospitalization duration |
Self-reported hospitalization duration in days |
Up to 40 weeks. Measured at four time points. Baseline (Q1), 2 (Q2), 4 (Q3), and 6 (Q4) weeks from baseline. |
|
Secondary |
Hospitalization duration |
As reported in the Norwegian Patient Registry in days among those with hospitalization |
up to 40 weeks |
|
Secondary |
Beliefs About Medication |
Beliefs About Medication were measured by Pregnant women's Beliefs About Medications - twelve Pregnancy-Specific Statements. Rated in "strongly agree", "agree", "uncertain", "disagree", and "strongly disagree" |
Up to 40 weeks. Measured at four time points. Baseline (Q1), 2 (Q2), 4 (Q3), and 6 (Q4) weeks from baseline. |
|
Secondary |
Risk evaluation |
Risk evaluation were measured by the risk evaluation scale containing 17 substances (egg, cheese, ginger, cranberry, folic acid/folate, smoking cigarettes, alcohol, X-ray, drugs for acid reflux, paracetamol, ibuprofen, antibiotics, meclizine, metoclopramide, ondansetron, thalidomide, swine flu vaccine). Women categorize the substances on a scale from 0 (not harmful) and 10 (very harmful) about how harmful they think these funds are during pregnancy |
Up to 40 weeks. Measured at four time points. Baseline (Q1), 2 (Q2), 4 (Q3), and 6 (Q4) weeks from baseline. |
|